Class information for:
Level 1: NON SMALL CELL LUNG CANCER//VINORELBINE//GEMCITABINE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
683 3165 31.9 71%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
216 3       NON SMALL CELL LUNG CANCER//LUNG CANCER//THORAC SURG 51214
1422 2             XRCC1//GEMCITABINE//ERCC1 7962
683 1                   NON SMALL CELL LUNG CANCER//VINORELBINE//GEMCITABINE 3165

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 NON SMALL CELL LUNG CANCER authKW 1150847 34% 11% 1074
2 VINORELBINE authKW 523782 7% 24% 226
3 GEMCITABINE authKW 380116 12% 10% 394
4 PEMETREXED authKW 367963 5% 22% 173
5 LUNG CANCER journal 350911 13% 9% 401
6 ADVANCED NON SMALL CELL LUNG CANCER authKW 315027 2% 47% 70
7 DOCETAXEL authKW 258221 10% 9% 308
8 CARBOPLATIN authKW 212962 8% 9% 239
9 NSCLC authKW 193820 8% 8% 243
10 ADVANCED NSCLC authKW 135945 1% 41% 34

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Oncology 90534 86% 0% 2708
2 Respiratory System 23106 22% 0% 712
3 Pharmacology & Pharmacy 600 11% 0% 334
4 Health Care Sciences & Services 80 2% 0% 48
5 Critical Care Medicine 63 1% 0% 39
6 Medicine, General & Internal 44 4% 0% 113
7 Health Policy & Services 32 1% 0% 25
8 Integrative & Complementary Medicine 12 0% 0% 12
9 Geriatrics & Gerontology 9 1% 0% 18
10 Hematology 1 1% 0% 32

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 THORAC ONCOL 67702 4% 6% 121
2 MED ONCOL 62368 17% 1% 549
3 PULM DIS 1 55802 0% 64% 9
4 MULTIDISCIPLINARY THORAC ONCOL PROGRAM 45737 1% 22% 22
5 THORAC ONCOL UNIT 31940 1% 15% 22
6 DIS MANAGEMENT TEAM LUNG CANC 30140 0% 63% 5
7 CHEST DIS 1 28938 0% 100% 3
8 CHEST DIS 2 28938 0% 100% 3
9 CHEST DIS 7 28938 0% 100% 3
10 LUNG CANC WORKING GRP 28938 0% 100% 3

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 LUNG CANCER 350911 13% 9% 401
2 SEMINARS IN ONCOLOGY 121434 8% 5% 256
3 CLINICAL LUNG CANCER 71352 2% 10% 75
4 JOURNAL OF THORACIC ONCOLOGY 61749 4% 5% 131
5 ANNALS OF ONCOLOGY 33362 5% 2% 169
6 CANCER TREATMENT REPORTS 25848 2% 4% 77
7 JOURNAL OF CLINICAL ONCOLOGY 22010 6% 1% 193
8 AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 20587 3% 2% 93
9 CANCER CHEMOTHERAPY AND PHARMACOLOGY 19423 4% 2% 122
10 REVUE DES MALADIES RESPIRATOIRES 6697 2% 1% 51

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class		 LCSH search Wikipedia search
1 NON SMALL CELL LUNG CANCER 1150847 34% 11% 1074 Search NON+SMALL+CELL+LUNG+CANCER Search NON+SMALL+CELL+LUNG+CANCER
2 VINORELBINE 523782 7% 24% 226 Search VINORELBINE Search VINORELBINE
3 GEMCITABINE 380116 12% 10% 394 Search GEMCITABINE Search GEMCITABINE
4 PEMETREXED 367963 5% 22% 173 Search PEMETREXED Search PEMETREXED
5 ADVANCED NON SMALL CELL LUNG CANCER 315027 2% 47% 70 Search ADVANCED+NON+SMALL+CELL+LUNG+CANCER Search ADVANCED+NON+SMALL+CELL+LUNG+CANCER
6 DOCETAXEL 258221 10% 9% 308 Search DOCETAXEL Search DOCETAXEL
7 CARBOPLATIN 212962 8% 9% 239 Search CARBOPLATIN Search CARBOPLATIN
8 NSCLC 193820 8% 8% 243 Search NSCLC Search NSCLC
9 ADVANCED NSCLC 135945 1% 41% 34 Search ADVANCED+NSCLC Search ADVANCED+NSCLC
10 CHEMOTHERAPY 114579 19% 2% 603 Search CHEMOTHERAPY Search CHEMOTHERAPY

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 STEWART, DJ , CHIRITESCU, G , DAHROUGE, S , BANERJEE, S , TOMIAK, EM , (2007) CHEMOTHERAPY DOSE - RESPONSE RELATIONSHIPS IN NON-SMALL CELL LUNG CANCER AND IMPLIED RESISTANCE MECHANISMS.CANCER TREATMENT REVIEWS. VOL. 33. ISSUE 2. P. 101-137 221 81% 12
2 SCULIER, JP , MORO-SIBILOT, D , (2009) FIRST- AND SECOND-LINE THERAPY FOR ADVANCED NONSMALL CELL LUNG CANCER.EUROPEAN RESPIRATORY JOURNAL. VOL. 33. ISSUE 4. P. 915-930 119 84% 29
3 DELBALDO, C , MICHIELS, S , ROLLAND, E , SYZ, N , SORIA, JC , LE CHEVALIER, T , PIGNON, JP , (2007) SECOND OR THIRD ADDITIONAL CHEMOTHERAPY DRUG FOR NON-SMALL CELL LUNG CANCER IN PATIENTS WITH ADVANCED DISEASE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - 92 88% 12
4 SANTOS, FN , DE CASTRIA, TB , CRUZ, MRS , RIERA, R , (2015) CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER IN THE ELDERLY POPULATION.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 10. P. - 71 83% 0
5 GOFFIN, J , LACCHETTI, C , ELLIS, PM , UNG, YC , EVANS, WK , (2010) FIRST-LINE SYSTEMIC CHEMOTHERAPY IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER A SYSTEMATIC REVIEW.JOURNAL OF THORACIC ONCOLOGY. VOL. 5. ISSUE 2. P. 260-274 52 83% 85
6 BARLESI, F , JACOT, W , ASTOUL, P , PUJOL, JL , (2006) SECOND-LINE TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW.LUNG CANCER. VOL. 51. ISSUE 2. P. 159-172 66 83% 33
7 AZZOLI, CG , BAKER, S , TEMIN, S , PAO, W , ALIFF, T , BRAHMER, J , JOHNSON, DH , LASKIN, JL , MASTERS, G , MILTON, D , ET AL (2009) AMERICAN SOCIETY OF CLINICAL ONCOLOGY CLINICAL PRACTICE GUIDELINE UPDATE ON CHEMOTHERAPY FOR STAGE IV NON-SMALL-CELL LUNG CANCER.JOURNAL OF CLINICAL ONCOLOGY. VOL. 27. ISSUE 36. P. 6251-6266 66 44% 415
8 DELBALDO, C , MICHIELS, S , SYZ, N , SORIA, JC , LE CHEVALIER, T , PIGNON, JP , (2004) BENEFITS OF ADDING A DRUG TO A SINGLE-AGENT OR A 2-AGENT CHEMOTHERAPY REGIMEN IN ADVANCED NON-SMALL-CELL LUNG CANCER - A META-ANALYSIS.JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. VOL. 292. ISSUE 4. P. 470-484 55 87% 182
9 SAAD, ED , ADAMOWICZ, K , KATZ, A , JASSEM, J , (2012) ASSESSMENT OF QUALITY OF LIFE IN ADVANCED NON-SMALL-CELL LUNG CANCER: AN OVERVIEW OF RECENT RANDOMIZED TRIALS.CANCER TREATMENT REVIEWS. VOL. 38. ISSUE 6. P. 807-814 65 71% 6
10 CERSOSIMO, RJ , (2002) LUNG CANCER: A REVIEW.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 59. ISSUE 7. P. 611 -642 109 51% 56

Classes with closest relation at Level 1


Rank Class id link
1 22701 PEMETREXED//MULTITARGETED ANTIFOLATE//AFFILIATED JIANGSU CANC HOSP
2 603 NON SMALL CELL LUNG CANCER//STAGE III//LOCALLY ADVANCED NON SMALL CELL LUNG CANCER
3 18265 VANDETANIB//NINTEDANIB//CEDIRANIB
4 147 GEFITINIB//EGFR MUTATION//ERLOTINIB
5 33403 HYPOTHETICAL REGIMEN//ABSOLUTE SURVIVAL ADVANTAGE//AGIN STUDIES
6 8385 GEMCITABINE//DEOXYCYTIDINE KINASE//HENT1
7 2966 METASTATIC BREAST CANCER//VINORELBINE//DOCETAXEL
8 7277 PACLITAXEL//CREMOPHOR EL//DOCETAXEL
9 1350 SMALL CELL LUNG CANCER//AMRUBICIN//PROPHYLACTIC CRANIAL IRRADIATION
10 31090 HIGH DENSITY SEEDING//IRF7 SIGNATURE//MACROMASS CULTURE

Go to start page